CUTTING EDGE LARYNGOLOGY 2024

Event Date: October 2, 2024
Location: The Royal Society of Medicine, London

Cutting Edge Laryngology promises to showcase the latest advancements in the field of laryngology. As part of our ongoing corporate partnership with the British Laryngology Association, we’re proud to be showcasing Peptest, an innovative, non-invasive diagnostic test that can help identify laryngopharyngeal reflux.


About BIOHIT HealthCare

BIOHIT HealthCare is a Finnish biotech company, headquartered in Helsinki, that specialises in the development, manufacture and distribution of kits and assays for the screening, diagnosis and monitoring of digestive diseases. Its core disease focus areas include stomach health and dyspepsia, reflux and acid dysregulation, Inflammatory Bowel Disease (IBD), functional gastrointestinal disorders (FGID), Irritable bowel syndrome (IBS), and gut microbiota dysbiosis. Innovating for Health www.biohithealthcare.co.uk

Recent Events

Exploring advances in TDM for IBD management: insights from our recent webinar

August 21, 2024
Unboxing of Peptest

The inside edge on Peptest for the diagnosis of silent reflux

May 20, 2024
National Well-Being

The UK’s health landscape and the endeavour for national well-being

May 10, 2024
Endoscopy in a hospital

Tackling the challenge of Helicobacter pylori in record time with the ULTRA-FAST UFT300 Quick Test

February 7, 2024